Application no. and date | 19709992.2 (espacenet) (Federated) (European Patent Register), 20190318 | Patent/reg. no. and date | DK/EP 3768241, 20210908 | Publication date | 20210127 | Priority no. and date | EP 18162664, 20180319 | EP pub. no. and date |
EP 3768241 20210127 | Effective date | | Applicant/owner | MC2 Therapeutics Limited, James House Emlyn Lane
Leatherhead Surrey KT22 7EP, GB | Applicant ref. no. | 6.2110.010 | Inventor | CRUTCHLEY, Nigel, c/o MC2 Therapeutics Limited James House, Emlyn Lane
Leatherhead Surrey KT22 7EP, GB, GEORGIOU, Michelle, c/o MC2 Therapeutics Limited James House, Emlyn Lane
Leatherhead Surrey KT22 7EP, GB, LENON, Stephen, c/o MC2 Therapeutics Limited James House, Emlyn Lane
Leatherhead Surrey KT22 7EP, GB, PRAESTEGAARD, Morten, c/o MC2 Therapeutics Limited James House, Emlyn Lane
Leatherhead Surrey KT22 7EP, GB | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | Opponent | | IPC Class | A61K 31/573 (2006.01) , A61K 31/593 (2006.01) , A61K 47/10 (2017.01) , A61K 47/22 (2006.01) , A61K 9/107 (2006.01) , A61P 17/06 (2006.01) | Title | Topisk sammensætning omfattende calcipotriol og betamethasondipropionat | Int. application no. | EP2019056735 | Int. publication no. | WO2019179958 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|